A recent study on esophageal cancer reported that FSCN1 may function as an RBP; FSCN1 binding to the PTK6 mRNA precursor was found to inhibit PTK6 transcription (Cai et al., 2022). The gene discussed is PTK6; the disease is esophageal cancer.